Nishiguchi, Fumi
Ishikawa, Hiroto
Amaki, Junichi
Komuku, Yuki
Kimura, Akiko
Gomi, Fumi http://orcid.org/0000-0003-0807-8817
Funding for this research was provided by:
AMO Japan
Article History
Received: 2 July 2020
Revised: 2 November 2020
Accepted: 9 November 2020
First Online: 18 November 2020
Compliance with ethical standards
:
: Fumi Gomi has received grants and a speaker fee from AMO Japan K. K, Bayer Yakuhin, Ltd., Novartis Pharma K.K., and Santen Pharmaceuticals Co., Ltd. Hiroto Ishikawa has received a speaker fee from AMO Japan K.K. All other authors have no conflicts of interest to declare.
: The current study was approved by the ethics committee of Hyogo College of Medicine (approval no. 2494). The current study was performed in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from all participants.
: The author grants the publisher the sole and exclusive license of the full copyright in the contribution, which license the publisher hereby accepts.